ROIV

NASDAQ · Biotechnology

Roivant Sciences Ltd

Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks

$34.01

+1.80 (+5.59%)

As of Jun 24, 9:40 PM ET ·

ROIV News1 articles

Immunovant Shares Surge on Promising Arthritis Drug Data

Immunovant shares soared 35% after its experimental rheumatoid arthritis drug, IMVT-1402, demonstrated high response rates in a difficult-to-treat patient population, prompting a re-rating by Wall Street.